Skip to main content
Signal8

Bassan Abraham

SEC insider (Form 3/4/5 filer). CIK 0001864485. Director at Rani Therapeutics Holdings, Inc. (RANI) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on May 28, 2026. Located in SAN JOSE, CA.

Companies Bassan Abraham has filed insider reports for

  • Rani Therapeutics Holdings, Inc. (RANI): Director
  • CARGO Therapeutics, Inc. (CRGX): Director
  • Septerna, Inc. (SEPN): Director
Bassan Abraham profile photo

Bassan Abraham

CIK: 0001864485

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Rani Therapeutics Holdings, Inc. logo
RANI

Rani Therapeutics Holdings, Inc.

Director
CARGO Therapeutics, Inc. logo
CRGX

CARGO Therapeutics, Inc.

Director
Septerna, Inc. logo
SEPN

Septerna, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    May 28, 2026
    Award

    Director Stock Option (Right to Buy)

    Direct
    123.6K shares-
  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Oct 23, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    100K shares-
  • CARGO Therapeutics, Inc. logo
    CRGX

    CARGO Therapeutics, Inc.

    Aug 19, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    25K shares-
  • CARGO Therapeutics, Inc. logo
    CRGX

    CARGO Therapeutics, Inc.

    Jun 18, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    25K shares-
  • Septerna, Inc. logo
    SEPN

    Septerna, Inc.

    Jun 17, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    16.6K shares-

1-5 of 5